Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity
The management of multidrug-resistant strains of cytomegalovirus after solid organ transplantation is challenging. This case report demonstrates the successful treatment of a multidrug-resistant strain of cytomegalovirus that may represent a valuable option for problematic cases. This report illustr...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868410/ https://www.ncbi.nlm.nih.gov/pubmed/33569064 http://dx.doi.org/10.3389/fimmu.2020.623178 |
_version_ | 1783648445936959488 |
---|---|
author | Wiening, Vanessa Schmidt, Tina Dahmen, Maximilian Siam, Sami Reuter, Stefan Pavenstädt, Hermann-Joseph Sester, Martina Suwelack, Barbara |
author_facet | Wiening, Vanessa Schmidt, Tina Dahmen, Maximilian Siam, Sami Reuter, Stefan Pavenstädt, Hermann-Joseph Sester, Martina Suwelack, Barbara |
author_sort | Wiening, Vanessa |
collection | PubMed |
description | The management of multidrug-resistant strains of cytomegalovirus after solid organ transplantation is challenging. This case report demonstrates the successful treatment of a multidrug-resistant strain of cytomegalovirus that may represent a valuable option for problematic cases. This report illustrates the emergence of a multidrug-resistant cytomegalovirus (CMV) UL54 mutant strain in a renal transplant recipient with severe lymphopenia and thrombocytopenia. We show that the combined treatment with high-dose intravenous cytomegalovirus-specific immunoglobulins (CMV-IVIG) after the switch to a mammalian target of rapamycin (mTOR)-inhibitor and cyclosporine A was a successful treatment alternative to direct antiviral treatment with high-dose ganciclovir and foscarnet. This treatment was associated with a quantitative induction of CMV-specific CD4 and CD8 T cells that showed maturation in phenotype and functionality with decreasing viral load. Our case report illustrates that high-dose CMV-IVIG and conversion of immunosuppressive drugs to mTOR inhibitors and cyclosporine A can be a successful treatment in a situation where the use of direct antiviral drugs was considered insufficient. |
format | Online Article Text |
id | pubmed-7868410 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78684102021-02-09 Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity Wiening, Vanessa Schmidt, Tina Dahmen, Maximilian Siam, Sami Reuter, Stefan Pavenstädt, Hermann-Joseph Sester, Martina Suwelack, Barbara Front Immunol Immunology The management of multidrug-resistant strains of cytomegalovirus after solid organ transplantation is challenging. This case report demonstrates the successful treatment of a multidrug-resistant strain of cytomegalovirus that may represent a valuable option for problematic cases. This report illustrates the emergence of a multidrug-resistant cytomegalovirus (CMV) UL54 mutant strain in a renal transplant recipient with severe lymphopenia and thrombocytopenia. We show that the combined treatment with high-dose intravenous cytomegalovirus-specific immunoglobulins (CMV-IVIG) after the switch to a mammalian target of rapamycin (mTOR)-inhibitor and cyclosporine A was a successful treatment alternative to direct antiviral treatment with high-dose ganciclovir and foscarnet. This treatment was associated with a quantitative induction of CMV-specific CD4 and CD8 T cells that showed maturation in phenotype and functionality with decreasing viral load. Our case report illustrates that high-dose CMV-IVIG and conversion of immunosuppressive drugs to mTOR inhibitors and cyclosporine A can be a successful treatment in a situation where the use of direct antiviral drugs was considered insufficient. Frontiers Media S.A. 2021-01-25 /pmc/articles/PMC7868410/ /pubmed/33569064 http://dx.doi.org/10.3389/fimmu.2020.623178 Text en Copyright © 2021 Wiening, Schmidt, Dahmen, Siam, Reuter, Pavenstädt, Sester and Suwelack http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Wiening, Vanessa Schmidt, Tina Dahmen, Maximilian Siam, Sami Reuter, Stefan Pavenstädt, Hermann-Joseph Sester, Martina Suwelack, Barbara Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity |
title | Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity |
title_full | Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity |
title_fullStr | Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity |
title_full_unstemmed | Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity |
title_short | Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity |
title_sort | case report: management of a multidrug-resistant cmv-strain in a renal transplant recipient by high-dose cmv-specific immunoglobulins, modulation in immunosuppression, and induction of cmv-specific cellular immunity |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868410/ https://www.ncbi.nlm.nih.gov/pubmed/33569064 http://dx.doi.org/10.3389/fimmu.2020.623178 |
work_keys_str_mv | AT wieningvanessa casereportmanagementofamultidrugresistantcmvstraininarenaltransplantrecipientbyhighdosecmvspecificimmunoglobulinsmodulationinimmunosuppressionandinductionofcmvspecificcellularimmunity AT schmidttina casereportmanagementofamultidrugresistantcmvstraininarenaltransplantrecipientbyhighdosecmvspecificimmunoglobulinsmodulationinimmunosuppressionandinductionofcmvspecificcellularimmunity AT dahmenmaximilian casereportmanagementofamultidrugresistantcmvstraininarenaltransplantrecipientbyhighdosecmvspecificimmunoglobulinsmodulationinimmunosuppressionandinductionofcmvspecificcellularimmunity AT siamsami casereportmanagementofamultidrugresistantcmvstraininarenaltransplantrecipientbyhighdosecmvspecificimmunoglobulinsmodulationinimmunosuppressionandinductionofcmvspecificcellularimmunity AT reuterstefan casereportmanagementofamultidrugresistantcmvstraininarenaltransplantrecipientbyhighdosecmvspecificimmunoglobulinsmodulationinimmunosuppressionandinductionofcmvspecificcellularimmunity AT pavenstadthermannjoseph casereportmanagementofamultidrugresistantcmvstraininarenaltransplantrecipientbyhighdosecmvspecificimmunoglobulinsmodulationinimmunosuppressionandinductionofcmvspecificcellularimmunity AT sestermartina casereportmanagementofamultidrugresistantcmvstraininarenaltransplantrecipientbyhighdosecmvspecificimmunoglobulinsmodulationinimmunosuppressionandinductionofcmvspecificcellularimmunity AT suwelackbarbara casereportmanagementofamultidrugresistantcmvstraininarenaltransplantrecipientbyhighdosecmvspecificimmunoglobulinsmodulationinimmunosuppressionandinductionofcmvspecificcellularimmunity |